Remove 2019 Remove Clinical Pharmacology Remove Drug Development
article thumbnail

2022 in review: Drug development milestones for tropical diseases

Pharmaceutical Technology

This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology. The post 2022 in review: Drug development milestones for tropical diseases appeared first on Pharmaceutical Technology.

article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

About the author Sherene Min, MD, MPH, is Vice President of Global Clinical Development at ViiV Healthcare , a role she assumed in October 2019. With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety.

article thumbnail

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

Putting Patients First Blog

Further discussion on the unique aspects of rare disease drug development, the associated challenges, and when waivers may be warranted would greatly benefit all stakeholders, including sponsors, patient organizations, clinical researchers, and regulators. NHC comments on FDA diversity in clinical trials guidance.